DongBang Medical Co., Ltd.

240550 KRX Technology Technology
KOSDAQ
₩5,580.00
-1.59%
Delayed · cached 15 min

Fair value analysis

240550
DongBang Medical Co., Ltd.
Technology›Technology
₩5,580.00
Close used for this calculation
₩9,705.44Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
57/100
Profitability8/25
Returns13/25
Balance Sheet18/25
Efficiency18/25
Growth8/25
Good
Quality radar
57Prof.8/25Ret.13/25Eff.18/25B.Sht18/25Growth8/25

Consensus fair value

₩9,705.44
Below FV
▲ +73.9% against the close used
Model range ₩5,529.12 – ₩11,440.00
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₩5,529.12Fair value₩9,705.44Bull₩11,440.00
FairClose
52-week traded range
52W low ₩4,750.0052W high ₩11,180.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading below the consensus fair value

DongBang Medical Co., Ltd. closed at ₩5,580.00, 42.5% below the consensus fair value of ₩9,705.44 drawn from 7 valuation models.

Financial DNA score 57/100 — Good. P/E of 9.8x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
₩10,720.73
+92.1%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=8%, r=10%, tg=3%, n=10yr
Graham Number
₩8,740.62
+56.6%
√(22.5 × EPS × BVPS)
EPS=572, BVPS=5936.17
P/E Fair Value
₩11,440.00
+105.0%
EPS × 20x (sector P/E)
EPS=572, Sector P/E=20x
EV/EBITDA
₩8,501.09
+52.3%
(EBITDA × 10x − Net Debt) ÷ Shares
EBITDA=17.01B
Book Value (P/B)
₩5,529.12
-0.9%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=5936.17, ROE=9.5%, g=3%, r=10%
Reverse DCF
₩5,580.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: -2.7% | Historical: 0%
Margin of Safety
₩7,725.34
+38.4%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=10300.45, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.